Lumos Diagnostics Holdings Ltd (asx:LDX) Share Price

Company Profile

Business description
Lumos Diagnostics Holdings Ltd is engaged in selling Products and providing Services to customers. Its product offering includes rapid, point-of-care diagnostic test products, mainly focused on the diagnosis and management of infectious diseases. Its product is FebriDx, a point-of-care test for detecting and differentiating viral and bacterial respiratory infections. Its Service offering includes contract research and development services specialising in innovation, development, manufacturing and commercialisation of point-of-care diagnostic test solutions. The Company has one operating segment, being the provision of point-of-care diagnostics goods and services. It operates in the United States and Australia, with the majority of revenue generated from the United States.
Contact
2724 Loker Avenue West
CarlsbadCA92010
USA
T: +1 855 586-6739
https://www.lumosdiagnostics.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
Employees

Recommended

The data and AI company is one of the world’s strongest private companies, but a PitchBook report says it’s unattractive at the current price.

Jacob Robbins | 21 September 2026

Morningstar analysts’ take on the takeover for this undervalued industrial player.

Esther Holloway | 20 September 2026

These companies are our favourite choices for investors wanting to boost Aussie equity exposure.

Tyger Fitzpatrick | 20 September 2026

Index	Last price	Change	% Change
All Ordinaries	8,919.10	3.60	-0.04%
CAC 40	8,112.46	47.44	0.59%
DAX 40	25,472.81	168.75	0.67%
Dow JONES (US)	51,682.64	95.40	-0.18%
FTSE 100	10,704.78	45.65	0.43%
HKSE	24,995.34	244.56	0.99%
NASDAQ	26,522.54	104.25	0.39%
Nikkei 225	65,018.95	882.70	1.38%
NZX 50 Index	13,821.20	82.06	0.60%
S&P 500	7,650.50	12.74	0.17%
S&P/ASX 200	8,731.90	0.70	0.01%
SSE Composite Index	3,949.91	38.04	0.97%